T cell receptor (TCR)-interacting molecule (TRIM) is a recently identified transmembrane adaptor protein, which is exclusively expressed in T cells. Here we demonstrate that in mature T cells, TRIM preferentially interacts with the TCR via the TCR-ζ chains and to a lesser extent via the CD3-ε/γ heterodimer. Transient or stable overexpression of TRIM in Jurkat T cells results in enhancement of TCR expression on the cell surface and elevated induction of Ca2+ mobilization after T cell activation. TRIM-mediated upregulation of TCR expression results from inhibition of spontaneous TCR internalization and stabilization of TCR complexes on the cell surface. Collectively, our data identify TRIM as a novel integral component of the TCR complex and suggest that one function of TRIM might be to modulate the strength of signals transduced through the TCR through regulation of TCR expression on the cell surface.
Skip Nav Destination
Article navigation
4 June 2001
Article Contents
Article|
June 04 2001
The Transmembrane Adaptor Protein Trim Regulates T Cell Receptor (Tcr) Expression and Tcr-Mediated Signaling via an Association with the Tcr ζ Chain
Henning Kirchgessner,
Henning Kirchgessner
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Search for other works by this author on:
Jes Dietrich,
Jes Dietrich
bInstitute of Medical Microbiology and Immunology, University of Copenhagen, DK-2200 Copenhagen, Denmark
Search for other works by this author on:
Jeanette Scherer,
Jeanette Scherer
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Search for other works by this author on:
Pia Isomäki,
Pia Isomäki
cKennedy Institute of Rheumatology Division, Imperial College School of Medicine,
Search for other works by this author on:
Vladimir Korinek,
Vladimir Korinek
dInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, 14220 Praque, Czech Republic
Search for other works by this author on:
Ivan Hilgert,
Ivan Hilgert
dInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, 14220 Praque, Czech Republic
Search for other works by this author on:
Eddy Bruyns,
Eddy Bruyns
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Search for other works by this author on:
Albrecht Leo,
Albrecht Leo
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Search for other works by this author on:
Andrew P. Cope,
Andrew P. Cope
cKennedy Institute of Rheumatology Division, Imperial College School of Medicine,
Search for other works by this author on:
Burkhart Schraven
Burkhart Schraven
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
eInstitute for Immunology, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany
Search for other works by this author on:
Henning Kirchgessner
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Jes Dietrich
bInstitute of Medical Microbiology and Immunology, University of Copenhagen, DK-2200 Copenhagen, Denmark
Jeanette Scherer
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Pia Isomäki
cKennedy Institute of Rheumatology Division, Imperial College School of Medicine,
Vladimir Korinek
dInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, 14220 Praque, Czech Republic
Ivan Hilgert
dInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, 14220 Praque, Czech Republic
Eddy Bruyns
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Albrecht Leo
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
Andrew P. Cope
cKennedy Institute of Rheumatology Division, Imperial College School of Medicine,
Burkhart Schraven
aInstitute for Immunology, Ruprecht-Karls University Heidelberg, D-69120 Heidelberg, Germany
eInstitute for Immunology, Otto-von-Guericke-University Magdeburg, 39120 Magdeburg, Germany
Abbreviations used in this paper: BFA, brefeldin A; LAT, linker for activation of T cells; SIT, SHP2-interacting transmembrane adaptor protein; SKAP-HOM, Src kinase–associated phosphoprotein homologue; TRIM, TCR-interacting molecule.
Received:
October 10 2000
Revision Requested:
March 23 2001
Accepted:
April 26 2001
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2001 The Rockefeller University Press
2001
The Rockefeller University Press
J Exp Med (2001) 193 (11): 1269–1284.
Article history
Received:
October 10 2000
Revision Requested:
March 23 2001
Accepted:
April 26 2001
Citation
Henning Kirchgessner, Jes Dietrich, Jeanette Scherer, Pia Isomäki, Vladimir Korinek, Ivan Hilgert, Eddy Bruyns, Albrecht Leo, Andrew P. Cope, Burkhart Schraven; The Transmembrane Adaptor Protein Trim Regulates T Cell Receptor (Tcr) Expression and Tcr-Mediated Signaling via an Association with the Tcr ζ Chain. J Exp Med 4 June 2001; 193 (11): 1269–1284. doi: https://doi.org/10.1084/jem.193.11.1269
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement